Clinical outcome after a totally implantable venous access port-related infection in cancer patients: A prospective study and review of the literature

Medicine (United States)

Volumn 91, Issue 6, 2012, Pages 309-318

  Lebeaux, David ^a   Larroque, Béatrice ^b   Gellen Dautremer, Justine ^a   Leflon Guibout, Véronique ^c   Dreyer, Chantal ^d   Bialek, Suzanne ^c   Froissart, Antoine ^a   Hentic, Olivia ^e   Tessier, Catherine ^a   Ruimy, Raymond ^c   Pelletier, Anne Laure ^e   Crestani, Bruno ^f   Fournier, Michel ^f   Papo, Thomas ^g   Barry, Béatrix ^h   Zarrouk, Virginie ^a   Fantin, Bruno ^a  

^a BEAUJON HOSPITAL   (France)

^b Unité d'Epidémiologie et de Recherche Clinique   (France)

^c Service de Microbiologie   (France)

^d Service d'Oncologie Médicale   (France)

^e Service d'Hépatologie EtGastroentérologie   (France)

^f Service de Pneumologie   (France)

^g Service de Médecine Interne   (France)

^h BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; VANCOMYCIN;

ABSCESS; ADULT; AGED; ANTIBIOTIC THERAPY; BACTERIAL ARTHRITIS; BACTERIAL ENDOCARDITIS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA; CANDIDIASIS; CATHETER INFECTION; CLINICAL TRIAL; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEVICE INFECTION; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SEPTIC SHOCK; SOLID TUMOR; SPONDYLITIS; STAPHYLOCOCCUS INFECTION; THROMBOPHLEBITIS; VASCULAR ACCESS; VASCULAR ACCESS DEVICE;

ADULT; AGED; AGED, 80 AND OVER; CATHETER-RELATED INFECTIONS; CATHETERS, INDWELLING; CENTRAL VENOUS CATHETERS; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 84869506279     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0b013e318275ffe1     Document Type: Review

References (64)

1. Adler A, Yaniv I, Steinberg R, Solter E, Samra Z, Stein J, Levy I. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients. J Hosp Infect. 2006;62:358-365. (Pubitemid 43192330)
2. Astagneau P, Maugat S, Tran-Minh T, Douard MC, Longuet P, Maslo C, Patte R, Macrez A, Brucker G. Long-term central venous catheter infection in HIV-infected and cancer patients: a multicenter cohort study. Infect Control Hosp Epidemiol. 1999;20:494-498.
3. Barbetakis N, Asteriou C, Kleontas A, Tsilikas C. Totally implantable central venous access ports. Analysis of 700 cases. J Surg Oncol. 2011;104:654-656.
4. Biffi R, Corrado F, de Braud F, de Lucia F, Scarpa D, Testori A, Orsi F, Bellomi M, Mauri S, Aapro M, Andreoni B. Long-term, totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer. 1997;33:1190-1194. (Pubitemid 27359634)
5. Biffi R, De Braud F, Orsi F, Pozzi S, Arnaldi P, Goldhirsch A, Rotmensz N, Robertson C, Bellomi M, Andreoni B. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients. Cancer. 2001;92:1204-1212. (Pubitemid 32861670)
6. Biffi R, de Braud F, Orsi F, Pozzi S, Mauri S, Goldhirsch A, Nole F, Andreoni B. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days. Ann Oncol. 1998;9:767-773. (Pubitemid 28394164)
7. Biffi R, Pozzi S, Agazzi A, Pace U, Floridi A, Cenciarelli S, Peveri V, Cocquio A, Andreoni B, Martinelli G. Use of totally implantable central venous access ports for high-dose chemotherapy and peripheral blood stem cell transplantation: results of a monocentre series of 376 patients. Ann Oncol. 2004;15:296-300. (Pubitemid 38262631)
8. Blot F, Nitenberg G, Chachaty E, Raynard B, Germann N, Antoun S, Laplanche A, Brun-Buisson C, Tancrede C. Diagnosis of catheter-related bacteraemia: a prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354:1071-1077. (Pubitemid 29452819)
9. Brown DF, Muirhead MJ, Travis PM, Vire SR, Weller J, Hauer-Jensen M. Mode of chemotherapy does not affect complications with an implantable venous access device. Cancer. 1997;80:966-972. (Pubitemid 27360480)
10. Brun-Buisson C, Abrouk F, Legrand P, Huet Y, Larabi S, Rapin M. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med. 1987;147:873-877. (Pubitemid 17082477)
11. Burlaud A, Mathieu D, Falissard B, Trivalle C. Mortality and bloodstream infections in geriatrics units. Arch Gerontol Geriatr. 2010;51:e106-109.
12. Caers J, Fontaine C, Vinh-Hung V, De Mey J, Ponnet G, Oost C, Lamote J, De Greve J, Van Camp B, Lacor P. Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer. 2005;13:325-331. (Pubitemid 40674838)
13. Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol. 1989;25:939-944. (Pubitemid 19148697)
14. Chang L, Tsai JS, Huang SJ, Shih CC. Evaluation of infectious complications of the implantable venous access system in a general oncologic population. Am J Infect Control. 2003;31:34-39. (Pubitemid 36216573)
15. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47:1245-1251. (Pubitemid 24361532)
16. Charvat J, Linke Z, Horaekova M, Prausova J. Implantation of central venous ports with catheter insertion via the right internal jugular vein in oncology patients: single center experience. Support Care Cancer. 2006;14:1162-1165. (Pubitemid 44898801)
17. Chen WT, Liu TM, Wu SH, Tan TD, Tseng HC, Shih CC. Improving diagnosis of central venous catheter-related bloodstream infection by using differential time to positivity as a hospital-wide approach at a cancer hospital. J Infect. 2009;59:317-323.
18. Chu VH, Woods CW, Miro JM, Hoen B, Cabell CH, Pappas PA, Federspiel J, Athan E, Stryjewski ME, Nacinovich F, Marco F, Levine DP, Elliott TS, Fortes CQ, Tornos P, Gordon DL, Utili R, Delahaye F, Corey GR, Fowler VG Jr. Emergence of coagulase-negative staphylococci as a cause of native valve endocarditis. Clin Infect Dis. 2008;46:232-242. (Pubitemid 351269162)
19. Crowley AL, Peterson GE, Benjamin DK Jr, Rimmer SH, Todd C, Cabell CH, Reller LB, Ryan T, Corey GR, Fowler VG Jr. Venous thrombosis in patients with short-and long-term central venous catheter-associated Staphylococcus aureus bacteremia. Crit Care Med. 2008;36:385-390. (Pubitemid 351158608)
20. Douard MC, Arlet G, Longuet P, Troje C, Rouveau M, Ponscarme D, Eurin B. Diagnosis of venous access port-related infections. Clin Infect Dis. 1999;29:1197-1202. (Pubitemid 30265639)
21. Everts RJ, Vinson EN, Adholla PO, Reller LB. Contamination of catheter-drawn blood cultures. J Clin Microbiol. 2001;39:3393-3394. (Pubitemid 32830351)
22. Fernandez-Hidalgo N, Almirante B, Calleja R, Ruiz I, Planes AM, Rodriguez D, Pigrau C, Pahissa A. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother. 2006;57:1172-1180. (Pubitemid 44644422)
23. Foley MJ. Radiologic placement of long-term central venous peripheral access system ports (PAS Port): results in 150 patients. J Vasc Interv Radiol. 1995;6:255-262.
24. Fortun J, Grill F, Martin-Davila P, Blazquez J, Tato M, Sanchez-Corral J, Garcia-San Miguel L, Moreno S. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 2006;58:816-821. (Pubitemid 44390959)
25. Fowler VG Jr, Justice A, Moore C, Benjamin DK Jr, Woods CW, Campbell S, Reller LB, Corey GR, Day NP, Peacock SJ. Risk factors for hematogenous complications of intravascular catheter-associated Staphylococcus aureus bacteremia. Clin Infect Dis. 2005;40:695-703. (Pubitemid 40381343)
26. Freytes CO, Reid P, Smith KL. Long-term experience with a totally implanted catheter system in cancer patients. J Surg Oncol. 1990;45:99-102. (Pubitemid 20353694)
27. Ghanem GA, Boktour M, Warneke C, Pham-Williams T, Kassis C, Bahna P, Aboufaycal H, Hachem R, Raad I. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore). 2007;86:54-60. (Pubitemid 46104920)
28. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168-1174. (Pubitemid 23361446)
29. Hsieh CC, Weng HH, Huang WS, Wang WK, Kao CL, Lu MS, Wang CS. Analysis of risk factors for central venous port failure in cancer patients. World J Gastroenterol. 2009;15:4709-4714.
30. Karnofsky DA. Meaningful clinical classification of therapeutic responses to anticancer drugs. Clin Pharmacol Ther. 1961;2:709-712.
31. Kock HJ, Pietsch M, Krause U, Wilke H, Eigler FW. Implantable vascular access systems: experience in 1500 patients with totally implanted central venous port systems. World J Surg. 1998;22:12-16. (Pubitemid 28027994)
32. Kollef MH. Time to get serious about infection prevention in the ICU. Chest. 2006;130:1293-1296. (Pubitemid 44786717)
33. Kuizon D, Gordon SM, Dolmatch BL. Single-lumen subcutaneous ports inserted by interventional radiologists in patients undergoing chemotherapy: incidence of infection and outcome of attempted catheter salvage. Arch Intern Med. 2001;161:406-410. (Pubitemid 32116557)
34. Kurul S, Saip P, Aydin T. Totally implantable venous-access ports: local problems and extravasation injury. Lancet Oncol. 2002;3:684-692. (Pubitemid 35314912)
35. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 2003;29:530-538. (Pubitemid 36523666)
36. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, Bashore T, Corey GR. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
37. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis. 2001;32:1776-1783. (Pubitemid 32532008)
38. Lyon RD, Griggs KA, Johnson AM, Olsen Jr. Long-term follow-up of upper extremity implanted venous access devices in oncology patients. J Vasc Interv Radiol. 1999;10:463-471. (Pubitemid 29190254)
39. McGregor JC, Rich SE, Harris AD, Perencevich EN, Osih R, Lodise TP Jr, Miller RR, Furuno JP. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin Infect Dis. 2007;45:329-337. (Pubitemid 47101029)
40. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, Raad II, Rijnders BJ, Sherertz RJ, Warren DK. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:1-45.
41. Minassian VA, Sood AK, Lowe P, Sorosky JI, Al-Jurf AS, Buller RE. Longterm central venous access in gynecologic cancer patients. J Am Coll Surg. 2000;191:403-409.
42. Mueller BU, Skelton J, Callender DP, Marshall D, Gress J, Longo D, Norton J, Rubin M, Venzon D, Pizzo PA. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol. 1992;10:1943-1948. (Pubitemid 23064207)
43. Nam S-H, Kim D-Y, Kim S-C, Kim I-K. Complications and risk factors of infection in pediatric hemato-oncology patients with totally implantable access ports (TIAPs). Pediatr Blood Cancer. 2010;54:546-551.
44. Narducci F, Jean-Laurent M, Boulanger L, El Bedoui S, Mallet Y, Houpeau JL, Hamdani A, Penel N, Fournier C. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre. Eur J Surg Oncol. 2011;37:913-918.
45. Ng F, Mastoroudes H, Paul E, Davies N, Tibballs J, Hochhauser D, Mayer A, Begent R, Meyer T. A comparison of Hickman line-and Port-a-Cath-associated complications in patients with solid tumours undergoing chemotherapy. Clin Oncol (R Coll Radiol). 2007;19:551-556. (Pubitemid 47181179)
46. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery. 1982;92:706-712. (Pubitemid 13091564)
47. Nosher JL, Bodner LJ, Ettinger LJ, Siegel RL, Gribbin C, Asch J, Drachtman RA. Radiologic placement of a low profile implantable venous access port in a pediatric population. Cardiovasc Intervent Radiol. 2001;24:395-399. (Pubitemid 34081421)
48. O'Dowd C, McRae LA, McMillan DC, Kirk A, Milroy R. Elevated preoperative C-reactive protein predicts poor cancer specific survival in patients undergoing resection for non-small cell lung cancer. J Thorac Oncol. 2010;5:988-992.
49. Pegues D, Axelrod P, McClarren C, Eisenberg BL, Hoffman JP, Ottery FD, Keidan RD, Boraas M, Weese J. Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol. 1992;49:156-162.
50. Penel N, Neu JC, Clisant S, Hoppe H, Devos P, Yazdanpanah Y. Risk factors for early catheter-related infections in cancer patients. Cancer. 2007;110:1586-1592. (Pubitemid 47463074)
51. Poyart C, Berche P, Trieu-Cuot P. Characterization of superoxide dismutase genes from gram-positive bacteria by polymerase chain reaction using degenerate primers. FEMS Microbiol Lett. 1995;131:41-45.
52. Poyart C, Quesne G, Boumaila C, Trieu-Cuot P. Rapid and accurate species-level identification of coagulase-negative staphylococci by using the sodA gene as a target. J Clin Microbiol. 2001;39:4296-4301. (Pubitemid 33117113)
53. Prins RC, Rademacher BL, Mongoue-Tchokote S, Alumkal JJ, Graff JN, Eilers KM, Beer TM. C-reactive protein as an adverse prognostic marker for men with castration-resistant prostate cancer (CRPC): confirmatory results. Urol Oncol. 2012;30:33-37. Epub 2010 Mar 6.
54. Raad I. Intravascular-catheter-related infections. Lancet. 1998;351:893-898. (Pubitemid 28121188)
55. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005;55:90-94. (Pubitemid 40192619)
56. Samaras P, Dold S, Braun J, Kestenholz P, Breitenstein S, Imhof A, Renner C, Stenner-Liewen F, PestalozziBC. Infectious port complications are more frequent in younger patients with hematologic malignancies than in solid tumor patients. Oncology. 2008;74:237-244.
57. Sehirali S, Inal MM, Ozsezgin S, Sanci M, Atli O, Nayki C, Yildirim Y, Tinar S. A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy. Int J Gynecol Cancer. 2005;15:228-232. (Pubitemid 40396957)
58. Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H. Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med. 2009;35:909-913.
59. Sotir MJ, Lewis C, Bisher EW, Ray SM, Soucie JM, Blumberg HM. Epidemiology of device-associated infections related to a long-term implantable vascular access device. Infect Control Hosp Epidemiol. 1999;20:187-191.
60. Soufir L, Timsit JF, Mahe C, Carlet J, Regnier B, Chevret S. Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk-adjusted, cohort study. Infect Control Hosp Epidemiol. 1999;20:396-401.
61. Torramade JR, Cienfuegos JA, Hernandez J-L, Pardo F, Benito C, Gonzalez J, Balen E, de Villa V. The complications of central venous access systems: a study of 218 patients. Eur J Surg. 1993;159:323-327. (Pubitemid 23205766)
62. Velasco E, Portugal RD, Salluh JI. A simple score to predict early death in adult cancer patients with bloodstream infections. J Infect. 2009;59:332-336.
63. Vescia S, Baumgartner AK, Jacobs VR, Kiechle-Bahat M, Rody A, Loibl S, Harbeck N. Management of venous port systems in oncology: a review of current evidence. Ann Oncol. 2008;19:9-15.
64. Wolosker N, Yazbek G, Nishinari K, Malavolta LC, Munia MA, Langer M, Zerati AE. Totally implantable venous catheters for chemotherapy: experience in 500 patients. Sao Paulo Med J. 2004;122:147-151. (Pubitemid 39545238)